Prefilled Syringes Market is expected to reach US$ 20,323.33 Million by 2034

Disposable Prefilled Syringes by Type Segment Drives Prefilled Syringes Market Growth     

According to our new research study named "Prefilled Syringes Market Forecast to 2034 – Global Analysis – by Type, Material, Product Type, Application, and Distribution Channel," the market was valued at US$ 8,836.00 Million in 2025 and is projected to reach US$ 20,323.33 Million by 2034; it is expected to register a CAGR of 9.9% during 2026–2034. The rising prevalence of chronic diseases, as well as advancements in biologics and biosimilars, and increasing adoption of self-administration and home healthcare, are driving the prefilled syringes market size. However, the high manufacturing and development costs and stringent regulatory requirements, and approval delays hinder the prefilled syringes market growth. The growing preference for self-administration and home-based healthcare is projected to bring new prefilled syringes market trends in the coming years.            

The increased prevalence of chronic diseases globally is mainly driving the demand for prefilled syringes across the globe, for injectable therapies such as diabetes and rheumatoid arthritis. Prefilled syringes provide accurate doses, are less prone to contamination than other delivery methods, and allow for easy administration in out-patient/at-home settings. According to the World Health Organization, at the end of 2022, approximately 830 million people (1 out of every 10 people) were living with diabetes. This figure represents a threefold increase over the number of people who had diabetes in 1990. The rise in the incidence of diabetes is more pronounced in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), as of 2022, 38.4 million people (11.6%) have diabetes in the US. Among these, 38.1 million are adults (14.7%). According to the International Diabetes Federation (IDF), by 2024, there will be 589 million adults aged 20 to 79 diagnosed with diabetes around the world. As populations age, this number will continue to increase.

Prefilled Syringes Market, by Region, 2025 (%)

---

Prefilled Syringes Market Trends, Size & Forecast by 2034

Download Free Sample

---

Prefilled Syringes Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Prefilled Syringes and Reusable Prefilled Syringes), Material (Glass Prefilled Syringes and Plastic Prefilled Syringes), Product Type (Single Chamber and Multi-Chamber), Application (Cancer, Diabetes, Cardiovascular Disease, Autoimmune Disease, Infectious Disease, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel)

Source: The Insight Partners Analysis

Regarding rheumatoid arthritis, the Global Burden of Disease Study published in 2021 (and reported on in 2023 studies) estimates that there were 17.9 million people globally suffering from this disease, with an age-standardized rate of 208.9 per 100,000 people. Additionally, the CDC reported in 2022 that about 18.9% of adult Americans (aged 18 to 64) have received a diagnosis of arthritis, including rheumatoid arthritis. More specifically, in the US, approximately 21.5% of women have received this diagnosis, compared to approximately 16.1% of men.

As reported by the UK Health Security Agency, the prevalence of rheumatoid arthritis among adults in the UK has been stable at approximately 1% as per the latest available data (2023). New products are being developed to meet this demand. The US Food & Drug Administration (FDA) approved the Tremoflo C2 Airwave Oscillometry System in June 2023 (although not directly a prefilled syringe, it reflects the continuing trend toward injectable medications). The FDA also approved the Vabysmo prefilled syringe from Roche in July 2024 for treating diabetic macular oedema. The European Medicines Agency approved biosimilars for denosumab in prefilled syringes in 2023 to treat osteoporosis, and as a result of rheumatoid arthritis, many people will benefit from improved management of their chronic conditions. These recent changes have contributed to increasing the use of prefilled syringes when treating patients who require ongoing injectable medications.    

Prefilled Syringes Market Analysis Based on Segmental Evaluation:

Based on type, the prefilled syringes market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger prefilled syringes market share in 2025. Disposable prefilled syringes are preferred due to convenience, reduced contamination risk, regulatory preference, lower costs, improved safety, and rising vaccination programs. 

By material, the prefilled syringes market includes glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger prefilled syringes market share in 2025. Glass prefilled syringes ensure drug stability, superior barrier properties, chemical compatibility, regulatory acceptance, and widespread biologics usage.

In terms of product type, the prefilled syringes market is divided into single-chamber and multi-chamber. The single-chamber segment held a larger prefilled syringes market share in 2025. Single-chamber prefilled syringes grow because of simpler design, ease of use, lower manufacturing complexity, reduced costs, and high-volume therapies globally. 

By application, the prefilled syringes market is divided into cancer, diabetes, cardiovascular disease, autoimmune disease, infectious disease, and others. Other applications made up a large part of the market in 2025. Other applications are expanding by use in neurological disorders, allergies, dermatological conditions, endocrine disorders, and respiratory diseases, increasing injectable therapy adoption. 

By distribution channel, the prefilled syringes market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment made up a large part of the market in 2025. Hospital pharmacy channels grow due to high patient inflow, critical care usage, physician preference, controlled storage, and institutional purchasing power. 

The geographical scope of the prefilled syringes market report includes the assessment of market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. North America dominated the largest prefilled syringes market share in 2024. Advanced healthcare infrastructure, strong biologics usage, and widespread vaccination programs drive demand. The US leads through high adoption of injectable therapies, technological innovation, and home-care integration. Canada benefits from supportive healthcare policies and chronic disease management initiatives. In Mexico, improving healthcare access and expanding pharmaceutical manufacturing are driving prefilled syringe adoption.

Gerresheimer AG, Schott Group, Nipro Medical Corporation, BD, Baxter International Inc., Terumo, YPSOMED, Weigao Group, Barun, and Deltamed are among the leading companies profiled in the prefilled syringes market report.  

Geographically, the market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).      

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com